Combined therapy with cytokine-induced killer cells and oncolytic adenovirus expressing IL-12 induce enhanced antitumor activity in liver tumor model

Combined therapy with cytokine-induced killer cells and oncolytic adenovirus expressing IL-12 induce enhanced antitumor activity in liver tumor model

Item
http://www.wikidata.org/entity/Q34427459
shRNA-armed conditionally replicative adenoviruses: a promising approach for cancer therapyEvidence for Oncolytic Virotherapy: Where Have We Got to and Where Are We Going?Cytokine-Induced Killer Cells As Pharmacological Tools for Cancer Immunotherapy.Oncolytic measles virus enhances antitumour responses of adoptive CD8+NKG2D+ cells in hepatocellular carcinoma treatment.Localized interleukin-12 delivery for immunotherapy of solid tumours.Global transcriptome-wide analysis of CIK cells identify distinct roles of IL-2 and IL-15 in acquisition of cytotoxic capacity against tumor.Immune cells: more than simple carriers for systemic delivery of oncolytic viruses.Intraperitoneal perfusion of cytokine-induced killer cells with local hyperthermia for advanced hepatocellular carcinoma.Cholangiocarcinoma-derived exosomes inhibit the antitumor activity of cytokine-induced killer cells by down-regulating the secretion of tumor necrosis factor-α and perforin.An update on new adoptive immunotherapy strategies for solid tumors with cytokine-induced killer cells.Combined therapy with CTL cells and oncolytic adenovirus expressing IL-15-induced enhanced antitumor activity.Oncolytic viruses-immunotherapeutics on the rise.Cytokine-induced killer cells: A novel immunotherapy strategy for leukemia.Local sustained delivery of oncolytic adenovirus with injectable alginate gel for cancer virotherapy.Potent anti-prostate cancer immune response induced by dendritic cells transduced with recombinant adenoviruses encoding 4-1BBL combined with cytokine-induced killer cells.Combination of E2F-1 promoter-regulated oncolytic adenovirus and cytokine-induced killer cells enhances the antitumor effects in an orthotopic rectal cancer model.Combination of oncolytic adenovirus and luteolin exerts synergistic antitumor effects in colorectal cancer cells and a mouse model.
P2860

Combined therapy with cytokine-induced killer cells and oncolytic adenovirus expressing IL-12 induce enhanced antitumor activity in liver tumor model

Item
http://www.wikidata.org/entity/Q34427459
description
2012 nî lūn-bûn
@nan
2012 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Combined therapy with cytokine ...... activity in liver tumor model
@ast
Combined therapy with cytokine ...... activity in liver tumor model
@en
Combined therapy with cytokine ...... activity in liver tumor model
@nl
type
label
Combined therapy with cytokine ...... activity in liver tumor model
@ast
Combined therapy with cytokine ...... activity in liver tumor model
@en
Combined therapy with cytokine ...... activity in liver tumor model
@nl
prefLabel
Combined therapy with cytokine ...... activity in liver tumor model
@ast
Combined therapy with cytokine ...... activity in liver tumor model
@en
Combined therapy with cytokine ...... activity in liver tumor model
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P5875
P698
P921
P932
P356
P1433
P1476
Combined therapy with cytokine ...... activity in liver tumor model
@en
P2093
P2860
P304
P31
P356
10.1371/JOURNAL.PONE.0044802
P407
P433
P478
P577
P5875
P698
P921
P932